Skip to main content

Advertisement

Table 2 EQ-VAS at baseline, values for selected subgroups (intention-to-treat analysis population)

From: The impact of a disease management programme for type 2 diabetes on health-related quality of life: multilevel analysis of a cluster-randomised controlled trial

Subgroup 1/subgroup 2 No of participants, subgroup 1/subgroup 2 EQ-VAS, mean [CI], subgroup 1 EQ-VAS, mean [CI], subgroup 2 p valuea
Overall study population 1464 70.1 [69.1;71.0]
Intervention/control 639/825 69.4 [68.0;70.8] 70.6 [69.3;71.8] 0.231
Female/male 700/764 68.4 [67.0;69.8] 71.6 [70.3;72.8] 0.001
No manifestation of coronary heart diseaseb/ any manifestation of coronary heart disease 1253/211 70.6 [69.6;71.6] 66.6 [64.1;69.2] 0.003
No macrovascular diabetic complicationc/ any macrovascular diabetic complication 1108/356 71.4 [70.3;72.4] 66.0 [64.1;68.0] < 0.001
Living with a partner/ living alone 1111/318 71.0 [69.9;72.0] 66.8 [64.8;68.8] < 0.001
Non Austrian/Austrian 80/1377 65.1 [60.6;69.7] 70.3 [69.4;71.3] 0.029
No higher education/ higher education 1327/117 69.9 [68.9;70.9] 72.1 [68.9;75.4] 0.202
Working fulltime/ not working fulltime 1255/202 69.7 [68.7;70.7] 72.4 [69.9;74.9] 0.050
  1. aIndependent T Test or Welch-Test, respectively
  2. bMyocardial infarction and/or PTCA/stenting and/or coronary bypass
  3. cMyocardial infarction and/or PTCA/stenting and/or coronary bypass and/or stroke and/or carotid surgery and/or amputation/gangrene and/or peripheral artery bypass or PTA